Amgen (Germany) Investor Sentiment

AMG Stock   265.60  2.30  0.86%   
Slightly above 62% of Amgen's investor base is looking to short. The analysis of current outlook of investing in Amgen Inc suggests that many traders are alarmed regarding Amgen's prospects. Amgen's investing sentiment can be driven by a variety of factors including economic data, Amgen's earnings reports, geopolitical events, and overall market trends.
  
over a week ago at news.google.com         
Jennison Associates LLC Sells 78,759 Shares of Amgen Inc. - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Is Amgen Inc. the Best Immunotherapy Stock to Buy Now - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Amgen must face lawsuit claiming it hid 10.7 billion tax bill - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
Amgen Inc. An Undervalued Wide Moat Stock to Buy According to Analysts - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Amgen stock slides 5 percent as analysts weigh in on drug study results - Seeking Alpha
Google News at Macroaxis
over two months ago at news.google.com         
Is Amgen Stock Outperforming The Nasdaq - Barchart
Google News at Macroaxis
over three months ago at news.google.com         
What You Need To Know Ahead Of Amgens Earnings Release - Barchart
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Inc. Is a Trending Stock Facts to Know Before Betting on It - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Nikko Asset Management Americas Inc. Invests 1.99 Million in Amgen Inc. - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Inc. Shares Sold by Carret Asset Management LLC - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Brookstone Capital Management Trims Stake in Amgen Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Inc. Shares Sold by Wellington Management Group LLP - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Nomura Holdings Inc. Makes New Investment in Amgen Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
MONECO Advisors LLC Cuts Stock Holdings in Amgen Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Inc. Short Interest Update - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.

Amgen Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Amgen Stock Analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.